Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Borg

Showing results (261-270 of 412) with videos related to

Pageof 42
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2017
Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial CellsAmy Chui, Tilini Gunatillake, Shaun P Brennecke, et al.
Cell Reports|October 9, 2012
Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasminAndre L Samson, Anja S Knaupp, Maithili Sashindranath, et al.
Diabetes|March 11, 2016
Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejectionMiranda A Coleman, Claire F Jessup, Jennifer A Bridge, et al.
Scientific Reports|July 9, 2016
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Human Molecular Genetics|May 1, 2007
Genetic determinants of mitochondrial contentJoanne E Curran, Matthew P Johnson, Thomas D Dyer, et al.
Scientific Reports|May 27, 2016
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Scandinavian Journal of Medicine & Science in Sports|March 19, 2024
Meta-analysis prediction intervals are under reported in sport and exercise medicineDavid N Borg, Franco M Impellizzeri, Samantha J Borg, et al.
Molecular Human Reproduction|December 23, 2017
Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunctionMartha Lappas, Sharon McCracken, Kelly McKelvey, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Scientific Reports|November 11, 2017
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetesMicheal S Ward, Nicole B Flemming, Linda A Gallo, et al.
Pageof 42

Showing results (261-270 of 412) with videos related to

Sort By:
Pageof 42
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2017
Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial CellsAmy Chui, Tilini Gunatillake, Shaun P Brennecke, et al.
Cell Reports|October 9, 2012
Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasminAndre L Samson, Anja S Knaupp, Maithili Sashindranath, et al.
Diabetes|March 11, 2016
Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejectionMiranda A Coleman, Claire F Jessup, Jennifer A Bridge, et al.
Scientific Reports|July 9, 2016
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Human Molecular Genetics|May 1, 2007
Genetic determinants of mitochondrial contentJoanne E Curran, Matthew P Johnson, Thomas D Dyer, et al.
Scientific Reports|May 27, 2016
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db miceLinda A Gallo, Micheal S Ward, Amelia K Fotheringham, et al.
Scandinavian Journal of Medicine & Science in Sports|March 19, 2024
Meta-analysis prediction intervals are under reported in sport and exercise medicineDavid N Borg, Franco M Impellizzeri, Samantha J Borg, et al.
Molecular Human Reproduction|December 23, 2017
Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunctionMartha Lappas, Sharon McCracken, Kelly McKelvey, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Scientific Reports|November 11, 2017
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetesMicheal S Ward, Nicole B Flemming, Linda A Gallo, et al.
Pageof 42